Therapeutic Evaluation of a C3-Targeting Small Nucleic Acid Drug in a Spontaneous Humanized C3 Glomerulopathy Mouse Model 2256845
The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)
DOI: 10.1093/jimmun/vkag141.364 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Juan Liang und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Introduction
Complement component C3 is central to the activation of the alternative pathway (AP), and its dysregulation drives C3 glomerulopathy, a severe renal autoimmune disease that lacks effective therapies.
Methods
To enable translational studies, we established a humanized C3G model, B6-hC3 mC3 KO, which overexpresses human C3 while lacking the endogenous murine C3. These mice spontaneously develop progressive glomerulopathy resembling human C3G pathology. Small nucleic acid drugs were administered to mice to evaluate drug efficacy.
Results
The disease phenotype observed in humanized C3 transgenic mice appears to arise from a dysfunctional interaction between human C3 protein and murine complement proteins, resulting in uncontrolled AP activation. Subcutaneous administration of C3-targeting small nucleic acid drugs effectively reduced serum C3 and plasma C3a levels, and downregulated the ratio of Ba (the activated fragment of complement factor B, CFB) to CFB, indicating suppression of AP hyperactivation. After 6 weeks of treatment, renal histology showed markedly reduced deposition of hC3 and diminished inflammatory cell infiltration.
Conclusion
B6-hC3 mC3 KO mice reproduce key immunopathological features of C3G and serve as a powerful platform for mechanistic studies and preclinical evaluation of complement-targeted therapeutics. Funding Source n/a Topic Categories Innate Immune Responses and Host Defense: Cellular Mechanisms (INC)
Zitieren
APA
Liang, J., & Zi, K. (2026). Therapeutic Evaluation of a C3-Targeting Small Nucleic Acid Drug in a Spontaneous Humanized C3 Glomerulopathy Mouse Model 2256845. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.364
Vancouver
Liang J, Zi K. Therapeutic Evaluation of a C3-Targeting Small Nucleic Acid Drug in a Spontaneous Humanized C3 Glomerulopathy Mouse Model 2256845. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.364
BibTeX
@article{Liang2026,
author = {Liang, Juan and Zi, Kaiyuan},
title = {Therapeutic Evaluation of a C3-Targeting Small Nucleic Acid Drug in a Spontaneous Humanized C3 Glomerulopathy Mouse Model 2256845},
journal = {The Journal of Immunology},
year = {2026},
volume = {215},
number = {Supplement_1},
doi = {10.1093/jimmun/vkag141.364}
}
EUVIMED